Stryker (SYK) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $3.69
- EPS estimate
- $3.49
- EPS surprise
- +5.78%
- Revenue surprise
- +0.15%
- Revenue
- $6.6B
- Revenue estimate
- $6.6B
- Reported
- Jul 30, 2026
Stryker reported Q2 2026 results on July 30, 2026. Earnings per share came in at $3.69, ahead of the $3.49 estimate by 5.78%. Revenue was $6.6 billion, 0.15% above the consensus. Compared with Q2 2025, EPS rose about 18% from $3.13 and revenue rose about 10% from $6.0 billion.
The longer record shows steady growth. Annual EPS rose each year, from $9.34 in 2022 to $10.60 in 2023, $12.19 in 2024 and $13.63 in 2025. The first half of 2026 adds up to $6.29, about 5% more than a year earlier. Q4 is the largest quarter of each year in the table, and Q4 2025 set the highs here at $4.47 per share and $7.2 billion in revenue. Over the last 20 quarters, Stryker beat the EPS estimate 15 times. Its largest miss was Q1 2026, at 12.77% below, when EPS of $2.60 came in under the $2.84 of a year earlier.
Stryker reported Q3 between October 28 and November 2 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether the year-over-year growth in Q2 carries into the third quarter.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | $3.49 | $3.69 | +5.78% | $6.6B | SEC |
| Q1 2026 | Apr 30, 2026 | $2.98 | $2.60 | −12.77% | $6.0B | SEC |
| Q4 2025 | Jan 29, 2026 | $4.40 | $4.47 | +1.68% | $7.2B | SEC |
| Q3 2025 | Oct 30, 2025 | $3.13 | $3.19 | +1.82% | $6.1B | SEC |
| Q2 2025 | Jul 31, 2025 | $3.07 | $3.13 | +2.00% | $6.0B | SEC |
| Q1 2025 | May 1, 2025 | $2.71 | $2.84 | +4.63% | $5.9B | SEC |
| Q4 2024 | Jan 28, 2025 | $3.87 | $4.01 | +3.57% | $6.4B | SEC |
| Q3 2024 | Oct 29, 2024 | $2.77 | $2.87 | +3.52% | $5.5B | SEC |
| Q2 2024 | Jul 30, 2024 | $2.79 | $2.81 | +0.66% | $5.4B | SEC |
| Q1 2024 | Apr 30, 2024 | $2.36 | $2.50 | +6.13% | $5.2B | SEC |
| Q4 2023 | Jan 30, 2024 | $3.27 | $3.46 | +5.85% | $5.8B | SEC |
| Q3 2023 | Nov 2, 2023 | $2.43 | $2.46 | +1.04% | $4.9B | SEC |
| Q2 2023 | Aug 3, 2023 | $2.38 | $2.54 | +6.69% | $5.0B | SEC |
| Q1 2023 | May 1, 2023 | $2.00 | $2.14 | +6.88% | $4.8B | SEC |
| Q4 2022 | Jan 31, 2023 | $2.84 | $3.00 | +5.78% | $5.2B | SEC |
| Q3 2022 | Oct 31, 2022 | $2.20 | $2.12 | −3.59% | $4.5B | SEC |
| Q2 2022 | Jul 26, 2022 | $2.27 | $2.25 | −1.06% | $4.5B | SEC |
| Q1 2022 | Apr 28, 2022 | $1.95 | $1.97 | +1.26% | $4.3B | SEC |
| Q4 2021 | Jan 27, 2022 | $2.72 | $2.71 | −0.46% | $4.7B | SEC |
| Q3 2021 | Oct 28, 2021 | $2.28 | $2.20 | −3.36% | $4.2B | SEC |
Quarterly revenue
Frequently asked questions
When did Stryker (SYK) last report earnings?
Stryker last reported on Jul 30, 2026, covering fiscal Q2 2026.
Did SYK beat earnings estimates?
Yes. Stryker reported EPS of $3.69 for Q2 2026 against a $3.49 estimate — a 5.78% beat.
How much revenue did SYK report last quarter?
Stryker reported $6.6B in revenue for Q2 2026, against a consensus estimate of $6.6B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.